Sickle Cell Disease Antibodies

With the support of the National Heart, Lung, and Blood Institute, Rockland has successfully developed a set of reagents that greatly facilitate research studies of Sickle Cell Disease (SCD) and potentially allow efficient, inexpensive, and rapid diagnosis of patients. SCD reagents are validated by Western blotting and ELISA and could be further optimized for compatibility with other immunoassays including Immunofluorescence or Flow Cytometry.